Variability in Phelan-McDermid syndrome in a cohort of 210 Individuals
Loading...
Download
Full text at PDC
Publication date
2022
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Frontiers Media
Citations
Exportar
Citation
Nevado, J., García-Miñaúr, S., Palomares-Bralo, M., Vallespín, E., Guillén-Navarro, E., Rosell, J., Bel-Fenellós, C., Mori, M. Á., Milá, M., Del Campo, M., Barrúz, P., Santos-Simarro, F., Obregón, G., Orellana, C., Pachajoa, H., Tenorio, J. A., Galán, E., Cigudosa, J. C., Moresco, A., Saleme, C., … Spanish PMS Working Group (2022). Variability in Phelan-McDermid Syndrome in a Cohort of 210 Individuals. Frontiers in genetics, 13, 652454. https://doi.org/10.3389/fgene.2022.652454
Abstract
Phelan-McDermid syndrome (PMS, OMIM# 606232) results from either different rearrangements at the distal region of the long arm of chromosome 22 (22q13.3) or pathogenic sequence variants in the SHANK3 gene. SHANK3 codes for a structural protein that plays a central role in the formation of the postsynaptic terminals and the maintenance of synaptic structures. Clinically, patients with PMS often present with global developmental delay, absent or severely delayed speech, neonatal hypotonia, minor dysmorphic features, and autism spectrum disorders (ASD), among other findings. Here, we describe a cohort of 210 patients with genetically confirmed PMS. We observed multiple variant types, including a significant number of small deletions (<0.5 Mb, 64/189) and SHANK3 sequence variants (21 cases). We also detected multiple types of rearrangements among microdeletion cases, including a significant number with post-zygotic mosaicism (9.0%, 17/189), ring chromosome 22 (10.6%, 20/189), unbalanced translocations (de novo or inherited, 6.4%), and additional rearrangements at 22q13 (6.3%, 12/189) as well as other copy number variations in other chromosomes, unrelated to 22q deletions (14.8%, 28/189). We compared the clinical and genetic characteristics among patients with different sizes of deletions and with SHANK3 variants. Our findings suggest that SHANK3 plays an important role in this syndrome but is probably not uniquely responsible for all the spectrum features in PMS. We emphasize that only an adequate combination of different molecular and cytogenetic approaches allows an accurate genetic diagnosis in PMS patients. Thus, a diagnostic algorithm is proposed.
Description
REDES/FIBHULP08. FIBHULP PI: 2735. FIBHULP Auchan Reserch Project. FIBHULP. Raregenomics (B2017/BMD-3721).
Referencias bibliográficas:
• Anderlid B.-M. Schoumans J. Annerén G. Sahlén S. Kyllerman M. Vujic M. et al. (2002a). Subtelomeric Rearrangements Detected in Patients with Idiopathic Mental Retardation. Am. J. Med. Genet. 107 (4), 275–284. 10.1002/ajmg.10029
• Anderlid B.-M. Schoumans J. Annerén G. Tapia-Paez I. Dumanski J. Blennow E. et al. (2002b). FISH-mapping of a 100-kb Terminal 22q13 Deletion. Hum. Genet. 110 (5), 439–443. 10.1007/s00439-002-0713-7
• Betancur C. Buxbaum J. D. (2013). SHANK3 Haploinsufficiency: a "common" but Underdiagnosed Highly Penetrant Monogenic Cause of Autism Spectrum Disorders. Mol. Autism 4 (1), 17. 10.1186/2040-2392-4-17
• Boccuto L. Lauri M. Sarasua S. M. Skinner C. D. Buccella D. Dwivedi A. et al. (2013). Prevalence of SHANK3 Variants in Patients with Different Subtypes of Autism Spectrum Disorders. Eur. J. Hum. Genet. 21, 310–316. 10.1038/ejhg.2012.175
• Boeckers T. M. (2006). The Postsynaptic Density. Cell Tissue Res 326 (2), 409–422. 10.1007/s00441-006-0274-5
• Bonaglia M. C. Giorda R. Beri S. De Agostini C. Novara F. Fichera M. et al. (2011). Molecular Mechanisms Generating and Stabilizing Terminal 22q13 Deletions in 44 Subjects with Phelan/McDermid Syndrome. Plos Genet. 7, e1002173. 10.1371/journal.pgen.1002173
• Bonaglia M. C. Giorda R. Borgatti R. Felisari G. Gagliardi C. Selicorni A. et al. (2001b). Disruption of the ProSAP2 Gene in a t(12;22)(q24.1;q13.3) Is Associated with the 22q13.3 Deletion Syndrome. Am. J. Hum. Genet. 69 (2), 261–268. 10.1086/321293
• Bonaglia M. C. Giorda R. Mani E. Aceti G. Anderld B. M. Baroncini A. et al. (2001a). Identification of a Recurrent Breakpoint within the SHANK3 Gene in the 22q13.3 Deletion Syndrome. Am. J. Hum. Genet. 69 (2), 261–268.
• Bowling K. M. Thompson M. L. Amaral M. D. Finnila C. R. Hiatt S. M. Engel K. L. et al. (2017). Genomic Diagnosis for Children with Intellectual Disability And/or Developmental Delay. Genome Med. 9, 43. 10.1186/s13073-017-0433-1
• Bramswig N. C. Lüdecke H.-J. Alanay Y. Albrecht B. Barthelmie A. Boduroglu K. et al. (2015). Exome Sequencing Unravels Unexpected Differential Diagnoses in Individuals with the Tentative Diagnosis of Coffin-Siris and Nicolaides-Baraitser Syndromes. Hum. Genet. 134 (6), 553–568. 10.1007/s00439-015-1535-8
• Brignell A. Gu C. Holm A. Carrigg B. Sheppard D. A. Amor D. J. et al. (2021). Speech and Language Phenotype in Phelan-McDermid (22q13.3) Syndrome. Eur. J. Hum. Genet. 29 (4), 564–574. 10.1038/s41431-020-00761-1
• Burdeus-Olavarrieta M. San José-Cáceres A. García-Alcón A. González-Peñas J. Hernández-Jusdado P. Parellada-Redondo M. (2021). Characterisation of the Clinical Phenotype in Phelan-McDermid Syndrome. J. Neurodevelop Disord. 13, 26–40. 10.1186/s11689-021-09370-5
• C Yuen R. K. Merico D. Bookman M. L HoweThiruvahindrapuram J. B. Thiruvahindrapuram B. Patel R. V. et al. (2017). Whole Genome Sequencing Resource Identifies 18 New Candidate Genes for Autism Spectrum Disorder. Nat. Neurosci. 20, 602–611. 10.1038/nn.4524
• Chen C.-H. Chen H.-I. Liao H.-M. Chen Y.-J. Fang J.-S. Lee K.-F. et al. (2017). Clinical and Molecular Characterization of Three Genomic Rearrangements at Chromosome 22q13.3 Associated with Autism Spectrum Disorder. Psychiatr. Genet. 27 (1), 23–33. 10.1097/ypg.0000000000000151
• Cooper G. M. Coe B. P. Girirajan S. Rosenfeld J. A. Vu T. H. Baker C. et al. (2011). A Copy Number Variation Morbidity Map of Developmental Delay. Nat. Genet. 43 (9), 838–846. 10.1038/ng.909
• Cusmano-Ozog K. Manning M. A. Hoyme H. E. (2007). 22q13.3 Deletion Syndrome: A Recognizable Malformation Syndrome Associated with Marked Speech and Language Delay. Am. J. Med. Genet. 145C, 393–398. 10.1002/ajmg.c.30155
• De Rubeis S. Siper P. M. Durkin A. Weissman J. Muratet F. Halpern D. et al. (2018). Delineation of the Genetic and Clinical Spectrum of Phelan-McDermid Syndrome Caused by SHANK3 point Mutations. Mol. Autism 9, 31. 10.1186/s13229-018-0205-9
• Delahaye A. Toutain A. Aboura A. Dupont C. Tabet A. C. Benzacken B. et al. (2009). Chromosome 22q13.3 Deletion Syndrome with a De Novo Interstitial 22q13.3 Cryptic Deletion Disrupting SHANK3. Eur. J. Med. Genet. 52 (5), 328–332. 10.1016/j.ejmg.2009.05.004
• Denayer A. Van Esch H. de Ravel T. Frijns J. P. Van Buggenhout G. Vogels A. et al. (2012). Neuropsychopathology in 7 Patients with the 22q13 Deletion Syndrome: Presence of Bipolar Disorder and Progressive Loss of Skills. Mol. Syndromol 3 (1), 14–20. 10.1159/000339119
• Dhar S. U. del Gaudio D. German J. R. Peters S. U. Ou Z. Bader P. I. et al. (2010). 22q13.3 Deletion Syndrome: Clinical and Molecular Analysis Using Array CGH. Am. J. Med. Genet. 152A, 573–581. 10.1002/ajmg.a.33253
• Disciglio V. Rizzo C. L. Mencarelli M. A. Mucciolo M. Marozza A. Di Marco C. et al. (2014). Interstitial 22q13 Deletions Not Involving SHANK3 Gene: a New Contiguous Gene Syndrome. Am. J. Med. Genet. 164 (7), 1666–1676. 10.1002/ajmg.a.36513
• Durand C. M. Betancur C. Boeckers T. M. Bockmann J. Chaste P. Fauchereau F. et al. (2007). Mutations in the Gene Encoding the Synaptic Scaffolding Protein SHANK3 Are Associated with Autism Spectrum Disorders. Nat. Genet. 39 (1), 25–27. 10.1038/ng1933
• Farwell K. D. Shahmirzadi L. El-Khechen D. Powis Z. Chao E. C. Tippin Davis B. et al. (2015). Enhanced Utility of Family-Centered Diagnostic Exome Sequencing with Inheritance Model-Based Analysis: Results from 500 Unselected Families with Undiagnosed Genetic Conditions. Genet. Med. 17 (7), 578–586. 10.1038/gim.2014.154
• Feliciano P. Zhou X. Astrovskaya I. Turner T. N. Wang T. Brueggeman L. et al. (2019). Exome Sequencing of 457 Autism Families Recruited Online Provides Evidence for Autism Risk Genes. NPJ Genom Med. 4, 19. 10.1038/s41525-019-0093-8
• Gauthier J. Spiegelman D. Piton A. Lafrenière R. G. Laurent S. St-Onge J. et al. (2009). Novel De Novo SHANK3 Mutation in Autistic Patients. Am. J. Med. Genet. 150B, 421–424. 10.1002/ajmg.b.30822
• Girirajan S. Eichler E. E. (2010). Phenotypic Variability and Genetic Susceptibility to Genomic Disorders. Hum. Mol. Genet. 19 (R2), R176–R187. 10.1093/hmg/ddq366
• Ha J. F. Ahmad A. Lesperance M. M. (2017). Clinical Characterization of Novel Chromosome 22q13. Microdeletions Int. J. Pediatr. Otorhinolaryngol. 95, 121–126.
• Heilstedt H. A. Ballif B. C. Howard L. A. Lewis R. A. Stal S. Kashork C. D. et al. (2003). Physical Map of 1p36, Placement of Breakpoints in Monosomy 1p36, and Clinical Characterization of the Syndrome. Am. J. Hum. Genet. 72 (5), 1200–1212. 10.1086/375179
• Holder J. L. JrQuach M. M. (2016). The Spectrum of Epilepsy and Electroencephalographic Abnormalities Due to SHANK3 Loss-Of-Function Mutations. Epilepsia 57 (10), 1651–1659. 10.1111/epi.13506
• Kaplanis J. Samocha K. E. Wiel L. Zhang Z. Arvai K. J. Eberhardt R. Y. et al. (2020). Evidence for 28 Genetic Disorders Discovered by Combining Healthcare and Research Data. Nature 586 (7831), 757–762. 10.1038/s41586-020-2832-5
• Kolevzon A. Delaby E. Berry-Kravis E. Buxbaum J. D. Betancur C. (2019). Neuropsychiatric Decompensation in Adolescents and Adults with Phelan-McDermid Syndrome: a Systematic Review of the Literature. Mol. Autism 10, 50. 10.1186/s13229-019-0291-3
• Kurtas N. Arrigoni F. Errichiello E. Zucca C. Maghini C. D’Angelo M. G. et al. (2018). Chromothripsis and Ring Chromosome 22: a Paradigm of Genomic Complexity in the Phelan-McDermid Syndrome (22q13 Deletion Syndrome). J. Med. Genet. 55 (4), 269–277. 10.1136/jmedgenet-2017-105125
• Leblond C. S. Nava C. Polge A. Gauthier J. Huguet G. Lumbroso S. et al. (2014). Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments. Plos Genet. 10, e1004580. 10.1371/journal.pgen.1004580
• Lelieveld S. H. Reijnders M. R. F. Pfundt R. Yntema H. G. Kamsteeg E.-J. de Vries P. et al. (2016). Meta-analysis of 2,104 Trios Provides Support for 10 New Genes for Intellectual Disability. Nat. Neurosci. 19, 1194–1196. 10.1038/nn.4352
• Li S. Xi K.-w. Liu T. Zhang Y. Zhang M. Zeng L.-d. et al. (2020). Fraternal Twins with Phelan-McDermid Syndrome Not Involving the SHANK3 Gene: Case Report and Literature Review. BMC Med. Genomics 13, 146–153. 10.1186/s12920-020-00802-0
• Lim E. T. Uddin M. Uddin M. De Rubeis S. Chan Y. Kamumbu A. S. et al. (2017). Rates, Distribution and Implications of Postzygotic Mosaic Mutations in Autism Spectrum Disorder. Nat. Neurosci. 20 (9), 1217–1224. 10.1038/nn.4598
• Lyons-Warren A. M. Cheung S. W. Holder J. L. Jr (2017). Clinical Reasoning: A Common Cause for Phelan-McDermid Syndrome and Neurofibromatosis Type 2. Neurology 89, e205–e209. 10.1212/wnl.0000000000004573
• Miller D. T. Adam M. P. Aradhya S. Biesecker L. G. Brothman A. R. R. Carter N. P. et al. (2010). Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies. Am. J. Hum. Genet. 86, 749–764. 10.1016/j.ajhg.2010.04.006
• Mitz A. R. Philyaw T. J. Boccuto L. Shcheglovitov A. Sarasua S. M. Kaufmann W. E. et al. (2018). Identification of 22q13 Genes Most Likely to Contribute to Phelan McDermid Syndrome. Eur. J. Hum. Genet. 26, 293–302. 10.1038/s41431-017-0042-x
• Nemirovsky S. I. Cordoba M. Zaiat J. J. Completa S. P. Vega P. A. Gonzalez-Moron D. et al. (2015). Whole-genome Sequencing Reveals a De Novo SHANK3 Mutation in Familial Autism Spectrum Disorder. PLoS One 10, e0116358. 10.1371/journal.pone.0116358
• Nevado J. Rosenfeld J. A. Mena R. Palomares-Bralo M. Vallespín E. Ángeles Mori M. et al. (2015). PIAS4 Is Associated with Macro/microcephaly in the Novel Interstitial 19p13.3 Microdeletion/microduplication Syndrome. Eur. J. Hum. Genet. 23 (12), 1615–1626. 10.1038/ejhg.2015.51
• O'Roak B. J. Stessman H. A. Boyle E. A. Witherspoon K. T. Martin B. Lee C. et al. (2014). Recurrent De Novo Mutations Implicate Novel Genes Underlying Simplex Autism Risk. Nat. Commun. 5, 5595. 10.1038/ncomms6595
• Oberman L. M. Boccuto L. Cascio L. Sarasua S. Kaufmann W. E. (2015). Autism Spectrum Disorder in Phelan-McDermid Syndrome: Initial Characterization and Genotype-Phenotype Correlations. Orphanet J. Rare Dis. 10, 105. 10.1186/s13023-015-0323-9
• Phelan K. Rogers R. C. Boccuto L. (2018). 22q13.3 Deletion Syndrome, Chromosome 22q13.3 Deletion Syndrome, Deletion 22q13 Syndrome. Genereviews.
• Retterer K. Juusola J. Cho M. T. Vitazka P. Millan F. Gibellini F. et al. (2016). Clinical Application of Whole-Exome Sequencing across Clinical Indications. Genet. Med. 18, 696–704. 10.1038/gim.2015.148
• Ricciardello A. Tomaiuolo P. Persico A. M. (2021). Genotype-phenotype Correlation in Phelan‐McDermid Syndrome: A Comprehensive Review of Chromosome 22q13 Deleted Genes. Am. J. Med. Genet. 185, 2211–2233. 10.1002/ajmg.a.62222
• Richards S. Aziz N. Bale S. Bick D. Das S. Gastier-Foster J. et al. (2015). Standards and Guidelines for the Interpretation of Sequence Variants: a Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424. 10.1038/gim.2015.30
• Rosenfeld J. A. Coe B. P. Eichler E. E. Cuckle H. Shaffer L. G. (2013). Estimates of Penetrance for Recurrent Pathogenic Copy-Number Variations. Genet. Med. 15 (6), 478–481. 10.1038/gim.2012.164
• Samogy-Costa C. I. Varella-Branco E. Monfardini F. Ferraz H. Fock R. A. Barbosa R. H. A. et al. (2019). A Brazilian Cohort of Individuals with Phelan-McDermid Syndrome: Genotype-Phenotype Correlation and Identification of an Atypical Case. J. Neurodevelop Disord. 11 (1), 13. 10.1186/s11689-019-9273-1
• Sarasua S. M. Boccuto L. Sharp J. L. Dwivedi A. Chen C.-F. Rollins J. D. et al. (2014a). Clinical and Genomic Evaluation of 201 Patients with Phelan-McDermid Syndrome. Hum. Genet. 133 (7), 847–859. 10.1007/s00439-014-1423-7
• Sarasua S. M. Dwivedi A. Boccuto L. Chen C.-F. Sharp J. L. Rollins J. D. et al. (2014b). 22q13.2q13.32 Genomic Regions Associated with Severity of Speech Delay, Developmental Delay, and Physical Features in Phelan-McDermid Syndrome. Genet. Med. 16, 318–328. 10.1038/gim.2013.144
• Sarasua S. M. Dwivedi A. Boccuto L. Rollins J. D. Chen C.-F. Rogers R. C. et al. (2011). Association between Deletion Size and Important Phenotypes Expands the Genomic Region of Interest in Phelan-McDermid Syndrome (22q13 Deletion Syndrome). J. Med. Genet. 48, 761–766. 10.1136/jmedgenet-2011-100225
• Sauer K. A. Bockmann J. Steionestel K. Boeckers T. M. Grabucker A. M. (2019). Altered Intestinal Morphology and Microbiota Composition in the Autism Spectrum Disorders Associated SHANK3 Mouse Model. Int. J. Mol. Sci. 20 (09), 2134. 10.3390/ijms20092134
• Schouten J. P. McElgunn C. J. Waaijer R. Zwijnenburg D. Diepvens F. Pals G. (2002). Relative Quantification of 40 Nucleic Acid Sequences by Multiplex Ligation-dependent Probe Amplification. Nucleic Acids Res. 30 (12), e57. 10.1093/nar/gnf056
• Shao L. Shaw C. A. Lu X.-Y. Sahoo T. Bacino C. A. Lalani S. R. et al. (2008). Identification of Chromosome Abnormalities in Subtelomeric Regions by Microarray Analysis: a Study of 5,380 Cases. Am. J. Med. Genet. 146A (17), 2242–2251. 10.1002/ajmg.a.32399
• Soorya L. Kolevzon A. Zweifach J. Lim T. Dobry Y. Schwartz L. et al. (2013). Prospective Investigation of Autism and Genotype-Phenotype Correlations in 22q13 Deletion Syndrome and SHANK3 Deficiency. Mol. Autism 4 (4), 18. 10.1186/2040-2392-4-18
• Srikanth S. Jain L. Zepeda-Mendoza C. Cascio Kelly Jones L. Pauly R. DuPont B. et al. (2021). Position Effects of 22q13 Rearrangements on Candidate Genes in Phelan- McDermid Syndrome. PLoS One 16 (7), e0253859. 10.1371/journal.pone.0253859
• Tabet A.-C. Rolland T. Ducloy M. Lévy J. Buratti J. Mathieu A. et al. (2017). A Framework to Identify Contributing Genes in Patients with Phelan-McDermid Syndrome. Npj Genom. Med. 2, 32. 10.1038/s41525-017-0035-2
• Tabolacci E. Zollino M. Lecce R. Sangiorgi E. Gurrieri F. Leuzzi V. et al. (2005). Two brothers with 22q13 Deletion Syndrome and Features Suggestive of the Clark???Baraitser Syndrome. Clin. Dysmorphol. 14, 127–132. 10.1097/00019605-200507000-00004
• Tenorio J. Nevado J. González‐Meneses A. Arias P. Dapía I. Venegas‐Vega C. A. et al. (2020). Further Definition of the Proximal 19p13.3 Microdeletion/microduplication Syndrome and Implication of PIAS4 as the Major Contributor. Clin. Genet. 97 (3), 467–476. 10.1111/cge.13689
• Thevenon J. Duffourd Y. Masurel-Paulet A. Lefebvre M. Feillet F. El Chehadeh-Djebbar S. et al. (2016). Diagnostic Odyssey in Severe Neurodevelopmental Disorders: toward Clinical Whole-Exome Sequencing as a First-Line Diagnostic Test. Clin. Genet. 89 (6), 700–707. 10.1111/cge.12732
• Vallespín E. Palomares Bralo M. MoriÁ. M. Á. Martín R. García-Miñaúr S. Fernández L. et al. (2013). Customized High Resolution CGH-Array for Clinical Diagnosis Reveals Additional Genomic Imbalances in Previous Well-Defined Pathological Samples. Am. J. Med. Genet. 161 (8), 1950–1960. 10.1002/ajmg.a.35960
• Verhoeven W. M. A. Egger J. Willemsen M. H. de Leijer G. J. Kleefstra T. (2012). Phelan-McDermid Syndrome in Two Adult brothers: Atypical Bipolar Disorder as its Psychopathological Phenotype? Ndt 8, 175–179. 10.2147/ndt.s30506
• Wilson H. L. Crolla J. A. Walker D. Artifoni L. Dallapiccola B. Takano T. et al. (2008). Interstitial 22q13 Deletions: Genes Other Than SHANK3 Have Major Effects on Cognitive and Language Development. Eur. J. Hum. Genet. 16, 1301–1310. 10.1038/ejhg.2008.107
• Wilson H. L. Wong A. C. Shaw S. R. Tse W. Y. Stapleton G. A. Phelan M. C. et al. (2003). Molecular Characterisation of the 22q13 Deletion Syndrome Supports the Role of Haploinsufficiency of SHANK3/PROSAP2 in the Major Neurological Symptoms. J. Med. Genet. 40, 575–584. 10.1136/jmg.40.8.575
• Xu N. Lv H. Yang T. Du X. Sun Y. Xiao B. et al. (2020). A 29 Mainland Chinese Cohort of Patients with Phelan-McDermid Syndrome: Genotype-Phenotype Correlations and the Role of SHANK3 Haploinsufficiency in the Important Phenotypes. Orphanet J. Rare Dis. 15 (1), 335. 10.1186/s13023-020-01592-5
• Zhang Y. Kong W. Gao Y. Liu X. Gao K. Xie H. et al. (2015). Gene Mutation Analysis in 253 Chinese Children with Unexplained Epilepsy and Intellectual/developmental Disabilities. PLoS One 10, e0141782. 10.1371/journal.pone.0141782
• Zhou W. Z. Zhang J. Li Z. Lin X. Li J. Wang S. et al. (2019). Targeted Resequencing of 358 Candidate Genes for Autism Spectrum Disorder in a Chinese Cohort Reveals Diagnostic Potential and Genotype-Phenotype Correlations. Hum. Mutat. 40 (6), 801–815. 10.1002/humu.23724
• Ziats C. A. Grosvenor L. P. Sarasua S. M. Thurm A. E. Swedo S. E. Mahfouz A. et al. (2019). Functional Genomics Analysis of Phelan-McDermid Syndrome 22q13 Region during Human Neurodevelopment. PLoS One 14, e0213921. 10.1371/journal.pone.0213921
• Ziats C. A. Jain L. McLarney B. Vandenboom E. DuPont B. R. Rogers C. et al. (2020). Neurofibromatosis Type 2 in Phelan-McDermid Syndrome: Institutional Experience and Review of the Literature. Eur. J. Med. Genet. 63 (11), 104042. 10.1016/j.ejmg.2020.104042
• Zwanenburg R. J. Ruiter S. A. J. van den Heuvel E. R. Flapper B. C. T. Van Ravenswaaij-Arts C. M. A. (2016). Developmental Phenotype in Phelan-McDermid (22q13.3 Deletion) Syndrome: a Systematic and Prospective Study in 34 Children. J. Neurodevelop Disord. 8, 16–28. 10.1186/s11689-016-9150-0